[1]
De Sanctis, V. et al. 2019. Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men.
Acta Biomedica Atenei Parmensis
. 90, 2 (May 2019), 228–232. DOI:
https://doi.org/10.23750/abm.v90i2.8477
.